Non-Small Cell Lung Cancer: Cemiplimab with Chemotherapy

We are studying whether adding new cancer treatments to cemiplimab and chemotherapy helps patients with operable non-small cell lung cancer. This trial aims to evaluate the effectiveness and safety of these combined treatments.

Efficacy phase (II)No PlaceboPartially RemoteInvestigational MedicinesInjectionOncologyPulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Carboplatin Hikma
Carboplatin Hikma is a chemotherapy medicine used to treat various types of cancer.
Libtayo
Libtayo is a cancer medicine that helps the immune system find and fight certain advanced skin and lung cancers.
Paclitaxel Aqvida
Paclitaxel Aqvida is a chemotherapy medicine used to treat various types of cancer.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Carboplatin
Carboplatin is a chemotherapy substance used to treat various cancers by damaging cancer cells and slowing tumor growth.
Cemiplimab
Cemiplimab is a substance that helps the immune system find and attack certain cancers by blocking a protein that suppresses immune cells.
Cisplatin
Cisplatin is a substance used in chemotherapy to kill or stop the growth of cancer cells.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Regn7075

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abutrax
Alimta
Alimta

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier De La Cote Basque
Medical Pneumology
Bayonne, France
Centre Hospitalier De La Cote Basque
Satellite site Oncology Department
Bayonne, France
Ramsay Generale De Sante
Oncology Department
Bayonne, France
Sponsor: Regeneron Pharmaceuticals Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.